Complix and Jiangsu Nhwa to collaborate on treatment of CNS Diseases
July 28, 2021Research and Development
Complix has signed a global collaboration and license agreement with Jiangsu Nhwa Pharmaceutical Co, to develop Cell Penetrating Alphabodies (CPABs), …
US to ship nearly 10 million vaccine doses to Nigeria and South Africa
July 28, 2021Research and Development
On Wednesday the US government will ship 4 million vaccine does to Nigeria and 5.66 million doses to South Africa. …
CanSino’s inhaled COVID vaccine performs well in early trials
July 28, 2021Manufacturing and Production, Research and Development
Early-stage data, published in The Lancet on Monday, has shown CanSino Biologic’s inhaled COVID-19 vaccine was able to stimulate neutralising …
Biogen withdrew Aduhelm paper when asked for edits from JAMA
July 28, 2021Research and Development
The makers of the controversial drug Aduhelm, Biogen, withdrew its paper that analysed the drug’s results that was submitted to …
AstraZeneca & Regeneron to develop small molecule obesity treatment
July 28, 2021Manufacturing and Production, Research and Development
AstraZeneca and Regeneron have announced a collaboration to research, develop and commercialise small molecule compounds directed against the GPR75 target …
Tokyo daily COVID cases hit record high
July 27, 2021Manufacturing and Production, Medical Communications
On Tuesday Tokyo reported 2,848 daily coronavirus infections, the city’s highest rate since the pandemic began. The new infection record …
Byondis and Glycotope to collaborate on antibodies against novel GlycoTargets
July 27, 2021Manufacturing and Production
Byondis and Glycotope have entered into a platform access agreement to discover and develop antibodies that target specific tumour-associated protein/carbohydrate …
BioNTech set to develop first mRNA malaria vaccine
July 27, 2021Manufacturing and Production, Research and Development
Buliding on the success of its COVID-19 vaccine, BioNTech has announced the development of the first mRNA vaccine against malaria, …
Antibodies from Sinovac’s COVID-19 vaccine fade after 6 months, study finds
July 27, 2021Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
A Chinese laboratory study has found that antibodies from Sinovac Biotech’s COVID-19 vaccine drop below a key threshold around six …
Purdue Pharma votes for bankruptcy plan to pay for its role in US opioid crisis
July 27, 2021Manufacturing and Production
Oxycontin makers Purdue Pharma have voted in favour of its bankruptcy reorganisation plan that will provide billions of dollars to …
US purchases further 200M Pfizer vaccines for children and possible boosters
July 26, 2021Sales and Marketing
The Biden administration has purchased an additional 200 million Pfizer-BioNTech COVID-19 vaccines for children, as well as for potential booster …
15-minute Covid-19 immune status test launched in the UK and Ireland
July 26, 2021Sales and Marketing
Luas Diagnostics has launched a 15-minute test to determine immunity to Covid-19 post infection or vaccination. The product, which is …
Moderna jab approved for children aged 12-17 in the EU
July 26, 2021Sales and Marketing
The EU has approved the use of the Moderna COVID vaccine in children aged 12-17. Pfizer’s jab got the green …
Latest UK figures show COVID cases are falling
July 26, 2021Sales and Marketing
The number of people testing positive with COVID-19 is falling in the UK. The UK recorded 29,173 new cases on …
FDA approves Beximco Pharma’s muscle relaxant drug Baclofen
July 26, 2021Sales and Marketing
Beximco Pharma has received FDA approval for Baclofen (10 and 20 mg tablets). Baclofen is a muscle relaxant drug indicated …
New NICE guideline on C. difficile rejects metronidazole prescription
July 23, 2021Medical Communications
NICE has published a new guideline covering C. difficile infection, the latest in the series of antimicrobial prescribing guidelines which …
Eight-week vaccine gap with Pfizer is best for antibodies
July 23, 2021Medical Communications
UK researchers have found an eight-week gap between first and second doses of the Pfizer-BioNTech appears to be the “sweet …
Expansion for first FDA-approved video game for ADHD treatment
July 23, 2021Medical Communications, Research and Development ADHD, FDA, US, digital therapeutics, technology
Akili Interactive has announced the expansion of its prescription video game treatment, EndeavorRx, with the addition of new gaming features …
Biogen pens open letter to Alzheimer’s community
July 23, 2021Medical Communications
In the wake of the controversial approval of Biogen’s Alzheimer’s drug, Aduhelm, the company has penned an open letter to …
Parents warned as child respiratory illness on the rise this summer
July 23, 2021Medical Communications
Parents are being warned to be on the lookout for signs of a common childhood respiratory illness, RSV, as cases …
Latest content
